NCT03728946View on ClinicalTrials.gov

Interscalene Block With and Without Liposomal Bupivacaine in Shoulder Surgery

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

November 21, 2018

Primary Completion Date

March 1, 2020

Study Completion Date

March 1, 2020

Conditions
Rotator Cuff TearPostoperative Pain
Interventions
DRUG

Liposomal Bupivacaine

Addition of 15mL of liposomal bupivacaine to 15mL of standard nerve block anesthetic solution containing 0.5% bupivacaine and 4mg of decadron

Trial Locations (6)

33410

Atlantis Orthopaedics, Palm Beach Gardens

97504

Southern Oregon Orthopedics, Inc., Medford

06830

Greenwich Hospital, Greenwich

06831

Orthopaedic & Neurosurgery Specialists, Greenwich

Atlantis Orthopaedics, Atlantis

06902

Stamford Ambulatory Surgical Center, Stamford

All Listed Sponsors
lead

Orthopaedic & Neurosurgery Specialists

OTHER

NCT03728946 - Interscalene Block With and Without Liposomal Bupivacaine in Shoulder Surgery | Biotech Hunter | Biotech Hunter